Compare Inovio Pharmaceuticals Inc (INO) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Virgin Galactic Holdings, Inc. trades at $3.33 (market cap $498.02M). The key difference: Virgin Galactic Holdings, Inc. is far larger — about 6.3× Inovio Pharmaceuticals Inc's market cap, and Virgin Galactic Holdings, Inc. is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | SPCE | |
|---|---|---|
Market Cap | $78.55M | $498.02M |
Sector | Health | Industrials |
52-Week High | $2.87 | $7.52 |
52-Week Low | $0.66 | $2.17 |
Enterprise Value | $49.56M | $597.87M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
